import { EducationalContent } from '../../types';

export const aorticAneurysm: EducationalContent = {
  id: 'aorticaneurysm',
  type: 'concept',
  name: 'Aortic Aneurysm',
  nameEs: 'Aneurisma Aortico',
  levels: {
    1: {
      level: 1,
      summary: 'An aortic aneurysm is an abnormal bulging or widening of the aorta, the body\'s largest artery, which can be life-threatening if it ruptures.',
      explanation: 'The aorta is the main artery that carries blood from the heart to the rest of the body. It is normally about 2-3 centimeters wide. An aortic aneurysm occurs when a section of the aorta becomes weakened and bulges outward, similar to a weak spot on an inflated balloon. The two main types are named by their location. An abdominal aortic aneurysm (AAA) occurs in the portion of the aorta that runs through the abdomen (belly area). This is the most common type, affecting about 4-8% of men over 65. A thoracic aortic aneurysm (TAA) occurs in the portion that runs through the chest. Most aortic aneurysms grow slowly over many years and cause no symptoms, which is why they are sometimes called "silent killers." The main danger is rupture, where the weakened wall tears open, causing massive internal bleeding that is fatal in about 80% of cases. Risk factors include smoking (the strongest modifiable risk factor for AAA), high blood pressure, age over 65, male sex, and family history. Because AAA is so often silent, screening with ultrasound is recommended for men aged 65-75 who have ever smoked. Small aneurysms are monitored with regular imaging. Large aneurysms (generally 5.5 cm or larger for AAA) are repaired surgically, either through traditional open surgery or with a minimally invasive procedure using a stent-graft placed through the blood vessels (endovascular repair).',
      keyTerms: [
        { term: 'Aortic aneurysm', definition: 'An abnormal widening or bulging of the aorta that increases the risk of life-threatening rupture' },
        { term: 'Abdominal aortic aneurysm (AAA)', definition: 'An aneurysm in the portion of the aorta below the diaphragm, in the abdominal region' },
        { term: 'Thoracic aortic aneurysm (TAA)', definition: 'An aneurysm in the portion of the aorta within the chest cavity' },
        { term: 'Rupture', definition: 'Tearing open of the aneurysm wall causing massive, often fatal internal bleeding' },
        { term: 'Screening', definition: 'Testing healthy people without symptoms to detect disease early, recommended for AAA in older male smokers' }
      ],
      clinicalNotes: 'The USPSTF recommends one-time screening for AAA with abdominal ultrasound in men aged 65-75 who have ever smoked. This screening reduces AAA-related mortality. Most aneurysms found on screening are small and only require surveillance. Patients should be counseled on smoking cessation and blood pressure control.'
    },
    2: {
      level: 2,
      summary: 'Aortic aneurysms are defined as dilation exceeding 50% of normal aortic diameter. AAA repair is indicated at 5.5 cm (men) or 5.0 cm (women), while TAA thresholds depend on location and etiology. Repair options include open surgical and endovascular approaches.',
      explanation: 'An aortic aneurysm is formally defined as a permanent, localized dilation of the aorta to at least 1.5 times (150%) the expected normal diameter. For the infrarenal aorta, this generally means a diameter of 3.0 cm or greater, since the normal infrarenal aorta is approximately 2.0 cm. The pathogenesis of AAA involves degradation of the aortic wall through chronic inflammation, proteolytic destruction of elastin and collagen by matrix metalloproteinases (MMPs, particularly MMP-2 and MMP-9), oxidative stress, and smooth muscle cell apoptosis. This is predominantly a degenerative/atherosclerotic process, unlike many TAAs which have a genetic component. Risk factors for AAA include: smoking (4-5x increased risk, the strongest risk factor), age greater than 65, male sex (6:1 male-to-female ratio), family history, hypertension, and hyperlipidemia. Protective factors include female sex, diabetes (paradoxically protective, possibly through advanced glycation endproducts stabilizing the wall), and African American race. AAA rupture risk increases exponentially with diameter: less than 1% per year at 4.0-4.9 cm, 1-11% per year at 5.0-5.9 cm, and 10-22% per year at 6.0-6.9 cm. Other risk factors for rupture include female sex (rupture at smaller diameters), rapid expansion (greater than 0.5 cm in 6 months or greater than 1.0 cm per year), smoking, uncontrolled hypertension, and family history of rupture. Repair indications for AAA: diameter 5.5 cm or greater in men, 5.0 cm or greater in women, rapid expansion, or symptoms (abdominal/back pain suggesting impending rupture). Thoracic aortic aneurysms have different thresholds: generally 5.5 cm for degenerative TAA, 5.0 cm for bicuspid aortic valve-associated disease with risk factors, 4.5-5.0 cm for Marfan syndrome, and 4.0-4.5 cm for Loeys-Dietz or vascular Ehlers-Danlos syndrome. Open surgical repair involves replacing the diseased segment with a synthetic graft (Dacron). Endovascular aneurysm repair (EVAR) for AAA involves placing a stent-graft through the femoral arteries to line the inside of the aneurysm, excluding it from blood flow. EVAR has lower perioperative mortality than open repair (1.2% vs 4.3%) but higher rates of reintervention and does not improve long-term overall survival. TEVAR (thoracic endovascular aortic repair) is performed for descending thoracic aneurysms.',
      keyTerms: [
        { term: 'Matrix metalloproteinases', definition: 'Enzymes that degrade structural proteins in the aortic wall, contributing to aneurysm formation and expansion' },
        { term: 'Endovascular aneurysm repair (EVAR)', definition: 'A minimally invasive procedure placing a stent-graft inside the aorta through femoral artery access to exclude the aneurysm' },
        { term: 'Dacron graft', definition: 'A synthetic fabric tube used to replace the diseased aortic segment during open surgical aneurysm repair' },
        { term: 'Rupture risk', definition: 'The annual probability of aneurysm rupture, which increases exponentially with aneurysm diameter' },
        { term: 'TEVAR', definition: 'Thoracic endovascular aortic repair, a catheter-based stent-graft procedure for descending thoracic aortic aneurysms' }
      ],
      clinicalNotes: 'Surveillance intervals for AAA: 2.6-2.9 cm, repeat ultrasound in 10 years; 3.0-3.9 cm, every 3 years; 4.0-4.9 cm, every 12 months; 5.0-5.4 cm, every 6 months. Always document the maximal outer-to-outer wall diameter in the anteroposterior plane. CT angiography is the gold standard for pre-operative planning and surveillance after EVAR.'
    },
    3: {
      level: 3,
      summary: 'Aortic aneurysm management requires understanding the genetic basis of thoracic disease, anatomic suitability for endovascular repair, management of endoleaks post-EVAR, and indications for concurrent aortic valve intervention in aortic root aneurysms.',
      explanation: 'Thoracic aortic aneurysms differ fundamentally from AAA in pathogenesis. While AAA is predominantly degenerative, TAA frequently has a genetic basis. Heritable thoracic aortic disease (HTAD) includes: Marfan syndrome (FBN1 gene mutation, fibrillin-1 deficiency leading to TGF-beta overactivity, affecting 1 in 5000, classic aortic root dilation), Loeys-Dietz syndrome (TGFBR1/2, SMAD3, TGFB2/3 mutations, aggressive aortopathy with more diffuse vascular involvement), vascular Ehlers-Danlos syndrome (COL3A1, type III collagen deficiency, highest risk of spontaneous arterial rupture), Turner syndrome (45,X, associated with bicuspid aortic valve and coarctation), and familial thoracic aortic aneurysm and dissection (FTAAD, involving ACTA2, MYH11, MYLK, PRKG1 genes, accounting for 20% of TAA without known syndromic features). First-degree relatives of patients with TAA or dissection should undergo screening with aortic imaging, and genetic testing should be considered when syndromic features are present or familial clustering exists. Anatomic assessment for EVAR requires careful CT angiography evaluation. Key criteria for standard infrarenal EVAR include: adequate proximal neck (at least 15 mm length of non-aneurysmal aorta below the renal arteries with less than 60 degree angulation and diameter 18-32 mm), adequate distal landing zones in the iliac arteries, and suitable access vessels (iliofemoral arteries large enough to accommodate the delivery system, typically 7 mm or more). Patients with hostile necks (short, angulated, thrombotic, or conical) have higher rates of complications with standard EVAR. Endoleaks are the most common complication of EVAR, classified by source: Type I (gutter leak at proximal or distal attachment site, requires immediate treatment), Type II (retrograde flow from branch vessels like lumbar or inferior mesenteric arteries, most common type, usually benign if sac is stable or shrinking), Type III (fabric tear or component disconnection, requires intervention), Type IV (porosity leak through intact graft fabric, usually transient), and Type V (endotension, sac growth without detectable endoleak). Post-EVAR surveillance with CT angiography monitors for endoleaks, sac growth, graft migration, and limb occlusion. Duplex ultrasound is increasingly used to reduce CT radiation exposure. Aortic root aneurysm management must consider the aortic valve. The David procedure (valve-sparing root replacement with reimplantation) is preferred for patients with aortic root aneurysm and a morphologically normal aortic valve, particularly in young patients and those with Marfan syndrome. The Bentall procedure (composite valve-graft replacement) uses a mechanical or bioprosthetic valved conduit. Selection depends on valve condition, patient age, and anticoagulation considerations.',
      keyTerms: [
        { term: 'Heritable thoracic aortic disease', definition: 'Genetic conditions predisposing to thoracic aortic aneurysm and dissection, including Marfan, Loeys-Dietz, and vascular Ehlers-Danlos syndromes' },
        { term: 'Endoleak', definition: 'Persistent blood flow into the aneurysm sac after endovascular repair, classified into five types by source and clinical significance' },
        { term: 'Proximal neck', definition: 'The segment of normal aorta between the renal arteries and the aneurysm where the EVAR stent-graft must seal' },
        { term: 'David procedure', definition: 'Valve-sparing aortic root replacement that preserves the native aortic valve while replacing the aneurysmal root and ascending aorta' },
        { term: 'Bentall procedure', definition: 'Aortic root replacement using a composite graft with an integrated prosthetic valve, used when both root and valve require replacement' },
        { term: 'ACTA2 mutation', definition: 'A gene encoding smooth muscle alpha-actin whose mutations cause familial thoracic aortic aneurysm and early-onset coronary and cerebrovascular disease' }
      ],
      clinicalNotes: 'For patients with suspected genetic aortopathy, referral to a genetics center is recommended. First-degree relatives should undergo screening echocardiography or CT/MRI. Surgical thresholds are lower for genetic conditions: Marfan at 5.0 cm (or 4.5 cm with risk factors), Loeys-Dietz at 4.0-4.2 cm by TEE (4.4-4.6 cm by CT/MRI due to measurement differences), and vascular EDS at 4.0-4.5 cm. Genetic diagnosis changes lifelong surveillance, activity restrictions, and family screening protocols.'
    },
    4: {
      level: 4,
      summary: 'Advanced aortic aneurysm management encompasses complex endovascular strategies for juxtarenal and thoracoabdominal aneurysms, fenestrated and branched endografts, hybrid procedures, and open thoracoabdominal repair with spinal cord protection strategies.',
      explanation: 'Complex aortic aneurysms that involve the visceral segment (renal arteries, superior mesenteric artery, celiac artery) or the thoracoabdominal aorta (Crawford classification: Type I extends from left subclavian to above renal arteries; Type II from left subclavian to below renal arteries, the most extensive; Type III from mid-descending thoracic to below renal arteries; Type IV from diaphragm to below renal arteries; Type V from mid-descending thoracic to above renal arteries) require advanced approaches. Fenestrated endovascular aortic repair (FEVAR) uses custom-designed stent-grafts with fenestrations (holes) or scallops aligned with the visceral arteries, allowing the graft to extend above the renal arteries while maintaining perfusion to branching vessels. This expands EVAR applicability to juxtarenal and pararenal aneurysms. Branched endovascular repair uses stent-grafts with side branches that connect to the visceral and renal arteries, enabling treatment of thoracoabdominal aneurysms endovascularly. These are technically demanding procedures with learning curve-dependent outcomes. Off-the-shelf devices (physician-modified endografts, parallel grafts/chimney technique) provide options when custom devices are not available or the case is urgent. Hybrid procedures combine open surgical bypass of the visceral vessels (creating new inflow from the iliac arteries) with endovascular stent-graft exclusion of the aneurysm. These debranching procedures reduce the physiologic stress of full thoracoabdominal open repair. Open thoracoabdominal aortic aneurysm (TAAA) repair remains the gold standard for Crawford Type II aneurysms in experienced centers. The procedure involves left thoracoabdominal incision, sequential clamping, visceral artery reimplantation, and distal aortic replacement. Spinal cord protection is the critical concern, as paraplegia rates range from 5-15% depending on extent. Protective strategies include: (1) Cerebrospinal fluid (CSF) drainage via lumbar drain (maintaining CSF pressure less than 10-15 mmHg increases spinal cord perfusion pressure); (2) Maintaining mean arterial pressure greater than 80-90 mmHg; (3) Sequential clamping to minimize total ischemia time; (4) Reimplanting critical intercostal arteries (T8-L1, particularly the artery of Adamkiewicz); (5) Hypothermia (moderate to deep); (6) Distal aortic perfusion via left heart bypass (femoral artery inflow to femoral vein). Motor evoked potential (MEP) and somatosensory evoked potential (SSEP) monitoring during surgery detects spinal cord ischemia in real time. In endovascular repair, delayed paraplegia can occur days after the procedure. Staging complex repairs (treating the thoracic component first, then the abdominal component weeks later) allows collateral development and reduces paraplegia risk. Post-operative monitoring in an ICU setting with CSF drainage maintained for 48-72 hours is standard.',
      keyTerms: [
        { term: 'Crawford classification', definition: 'A classification system for thoracoabdominal aortic aneurysms based on extent of aortic involvement, guiding surgical approach and risk assessment' },
        { term: 'Fenestrated endograft', definition: 'A custom-designed stent-graft with openings aligned to visceral arteries, enabling endovascular repair of aneurysms involving branch vessels' },
        { term: 'Cerebrospinal fluid drainage', definition: 'Placement of a lumbar drain to reduce CSF pressure and improve spinal cord perfusion during aortic surgery, reducing paraplegia risk' },
        { term: 'Artery of Adamkiewicz', definition: 'The largest anterior segmental artery supplying the spinal cord (typically arising between T9-T12), critical to preserve during aortic surgery' },
        { term: 'Motor evoked potentials', definition: 'Intraoperative neurophysiologic monitoring technique that detects spinal cord ischemia by measuring motor pathway conduction in real time' }
      ],
      clinicalNotes: 'Spinal cord ischemia after aortic repair is a devastating complication. Key preventive strategies: (1) Always place a CSF drain for Crawford II/III TAAA repair and consider for any procedure covering extensive aortic length with endografts. (2) Maintain MAP >80 mmHg for 48-72 hours post-procedure. (3) Stage extensive endovascular repairs when possible (thoracic then abdominal, 4-6 weeks apart). (4) Avoid hypotension and anemia (target Hgb >10 g/dL). (5) Maintain CSF drain for 48-72 hours post-op. If delayed paraplegia develops, immediately increase MAP, drain CSF, and correct anemia.'
    },
    5: {
      level: 5,
      summary: 'Expert aortic aneurysm management integrates precision genetics for surveillance and surgical thresholds, biomechanical rupture risk modeling, advanced endovascular technologies, pharmacologic growth limitation strategies, and long-term population health implications of screening programs.',
      explanation: 'The genomics of aortic aneurysm disease is rapidly evolving. Beyond classic syndromic causes, genome-wide association studies have identified risk loci for AAA (including DAB2IP on chromosome 9p21, LRP1, SORT1, IL6R, and MMP9) and for TAA (FBN1 common variants, ACTA2, LOX). Polygenic risk scores are being developed to identify individuals at highest genetic risk for aneurysm development and rupture. For HTAD, genetic testing panels covering 11+ genes are now standard. Cascade genetic testing of family members allows targeted surveillance of mutation carriers while releasing non-carriers from unnecessary lifelong imaging. The ACTA2 mutation deserves special attention: it causes not only TAA but also premature coronary and cerebrovascular disease, livedo reticularis, and iris flocculi, and carries surgical thresholds of 4.5 cm for the ascending aorta. Biomechanical modeling of aortic aneurysm rupture risk is moving beyond simple diameter-based criteria. Finite element analysis (FEA) using patient-specific CT-derived aortic geometry can estimate wall stress distribution. Peak wall stress (PWS) and peak wall rupture index (PWRI, the ratio of wall stress to estimated wall strength) may better predict rupture risk than diameter alone. The A4 clinics (Aortic Aneurysm Assessment and Advice) concept integrates biomechanical assessment into clinical decision-making for patients with AAA below current surgical thresholds but with concerning morphologic features (asymmetric sac, rapid focal expansion, high wall stress). Pharmacologic strategies to limit aneurysm growth are an active area of research. For AAA, doxycycline (MMP inhibitor) showed promise in preclinical studies but failed in clinical trials (the PHAST trial). ACE inhibitors and ARBs have conflicting data. Statins may slow growth through anti-inflammatory effects but evidence is limited. Metformin has emerged as a promising candidate, with multiple observational studies showing reduced AAA growth rate and lower rupture risk in diabetic patients (which may partly explain the diabetes paradox in AAA). Prospective trials (MAAACS, MetAAA) are ongoing. For Marfan-associated TAA, losartan was hypothesized to reduce TGF-beta signaling and slow aortic growth. However, the randomized COMPARE and Pediatric Heart Network trials showed losartan was not superior to atenolol. Beta-blockers remain the standard of care. Irbesartan is being studied (AIMS trial). Advanced endovascular technologies include: (1) Inner branched arch devices for aortic arch aneurysms (zone 0-2 landing), reducing the need for open arch replacement and hypothermic circulatory arrest; (2) Physician-modified endografts (PMEGs) created by surgeon modification of commercially available devices in urgent/emergent settings; (3) 3D-printed patient-specific guides for fenestration and branch alignment; (4) Robotic catheter navigation for complex branch vessel cannulation; (5) Drug-eluting endografts releasing anti-inflammatory agents to reduce endoleak and aortic sac inflammatory response. Population health considerations: the UK and Swedish AAA screening programs have demonstrated mortality reduction of 42-48% in screened populations. However, the declining prevalence of smoking has reduced AAA prevalence (from 5-8% to 1.5-2.5% in contemporary cohorts), raising questions about cost-effectiveness of universal screening. Risk-stratified screening approaches using clinical risk factors, family history, and potentially genetic risk scores may improve efficiency. The psychological impact of AAA diagnosis (aneurysm-related anxiety) and the quality-of-life implications of long-term surveillance are increasingly recognized considerations.',
      keyTerms: [
        { term: 'Peak wall stress', definition: 'The maximum mechanical stress in the aneurysm wall estimated by finite element analysis, potentially a better predictor of rupture than diameter alone' },
        { term: 'Polygenic risk score', definition: 'A combined genetic risk metric aggregating the effects of multiple common variants to predict individual susceptibility to aneurysm disease' },
        { term: 'Fenestrated and branched devices', definition: 'Advanced endovascular stent-grafts with fenestrations or side branches to maintain perfusion of visceral arteries during complex aneurysm repair' },
        { term: 'Metformin for AAA', definition: 'An emerging pharmacologic strategy based on observational data suggesting metformin may slow AAA growth and reduce rupture risk' },
        { term: 'Inner branched arch device', definition: 'An advanced endograft with pre-formed branches for the arch vessels, enabling endovascular treatment of aortic arch aneurysms' },
        { term: 'Cascade genetic testing', definition: 'Sequential genetic testing of family members after identification of a pathogenic variant in a proband, enabling targeted surveillance' }
      ],
      clinicalNotes: 'For the expert managing aortic aneurysm disease, the paradigm is shifting from "watch and wait until the diameter reaches threshold" to individualized risk assessment integrating: (1) genetics (syndromic vs. non-syndromic, specific gene mutation and its associated risk); (2) biomechanics (wall stress, sac morphology); (3) growth kinetics (rate of expansion, not just absolute size); (4) patient factors (sex, body size, family history of rupture); and (5) procedural risk (anatomic suitability, comorbidities). This personalized approach may enable earlier intervention in high-risk patients and avoid unnecessary surgery in low-risk patients.'
    }
  },
  media: [],
  citations: [
    {
      id: 'chaikof-2018',
      text: 'Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2-77.',
      url: 'https://doi.org/10.1016/j.jvs.2017.10.044'
    },
    {
      id: 'isselbacher-2022',
      text: 'Isselbacher EM, Preventza O, Black JH, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease. J Am Coll Cardiol. 2022;80(24):e223-e393.',
      url: 'https://doi.org/10.1016/j.jacc.2022.08.004'
    },
    {
      id: 'hiratzka-2010',
      text: 'Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients with Thoracic Aortic Disease. Circulation. 2010;121(13):e266-e369.',
      url: 'https://doi.org/10.1161/CIR.0b013e3181d4739e'
    }
  ],
  crossReferences: [
    { contentId: 'aorticdissection', relationship: 'related', description: 'Aortic aneurysms predispose to aortic dissection, and management overlaps for both conditions' },
    { contentId: 'vasculardisease', relationship: 'parent', description: 'Aortic aneurysm is a major component of vascular disease' }
  ],
  tags: {
    defined: ['aortic-aneurysm', 'AAA', 'TAA', 'EVAR', 'TEVAR', 'thoracoabdominal', 'Marfan-syndrome', 'aortic-screening', 'endoleak'],
    source: ['SVS', 'ACC', 'AHA', 'ESC', 'ESVS']
  },
  createdAt: '2025-01-25',
  updatedAt: '2025-01-25',
  version: 2,
  status: 'published'
};
